Nanog inhibits lipopolysaccharide-induced expression of pro-inflammatory cytokines by blocking NF-κB transcriptional activity in rat primary microglial cells

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 842-846

  Zhou, Haitao ^a   Chen, Shiyan ^a   Wang, Wei ^a   Wang, Zhiqiang ^a   Wu, Xiuli ^a   Zhang, Zhijian ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Inflammation; Microglia; Nanog; NF B

Indexed keywords

ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; TRANSCRIPTION FACTOR NANOG; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; INFLAMMATION; MICROGLIA; NONHUMAN; RAT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICROGLIA; NF-KAPPA B; RATS; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84863050471     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.719     Document Type: Article

References (29)

1. Graeber MB: Changing face of microglia. Science 330: 783-788, 2010.
2. Burguillos MA, Deierborg T, Kavanagh E, et al: Caspase signalling controls microglia activation and neurotoxicity. Nature 472: 319-324, 2011.
3. Block ML, Zecca L and Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69, 2007. (Pubitemid 46011999)
4. Mitsui K, Tokuzawa Y, Itoh H, et al: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642, 2003. (Pubitemid 36694188)
5. Chambers I, Colby D, Robertson M, et al: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003. (Pubitemid 36694189)
6. Silva J, Nichols J, Theunissen TW, et al: Nanog is the gateway to the pluripotent ground state. Cell 138: 722-737, 2009.
7. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
8. Torres J and Watt FM: Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat Cell Biol 10: 194-201, 2008. (Pubitemid 351194049)
9. Widera D, Mikenberg I, Kaltschmidt B and Kaltschmidt C: Potential role of NF-kappaB in adult neural stem cells: the underrated steersman? Int J Dev Neurosci 24: 91-102, 2006. (Pubitemid 43294615)
10. Lee EJ, Chen HY, Hung YC, et al: Therapeutic window for cinnamophilin following oxygen-glucose deprivation and transient focal cerebral ischemia. Exp Neurol 217: 74-83, 2009.
11. Keene CD, Chang R, Stephen C, et al: Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2. Am J Pathol 174: 2300-2309, 2009.
12. Morales I, Farias G and Maccioni RB: Neuroimmuno-modulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 17: 202-204, 2010.
13. Yokoyama H, Uchida H, Kuroiwa H, Kasahara J and Araki T: Role of glial cells in neurotoxin-induced animal models of Parkinson's disease. Neurol Sci 32: 1-7, 2011.
14. Niederberger E and Geisslinger G: The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J 22: 3432-3442, 2008.
15. Bajramovic JJ: Regulation of innate immune responses in the central nervous system. CNS Neurol Disord Drug Targets 10: 4-24, 2011.
16. Agostinho P, Cunha RA and Oliveira C: Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 16: 2766-2778, 2010.
17. Lucas SM, Rothwell NJ and Gibson RM: The role of inflammation in CNS injury and disease. Br J Pharmacol 147 (Suppl 1): 232-240, 2006.
18. Harry GJ and Kraft AD: Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol 4: 1265-1277, 2008.
19. Garden GA and Moller T: Microglia biology in health and disease. J Neuroimmune Pharmacol 1: 127-137, 2006. (Pubitemid 44257488)
20. Moynagh PN: The NF-kappaB pathway. J Cell Sci 118: 4589-4592, 2005.
21. Rius J, Guma M, Schachtrup C, et al: NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811, 2008. (Pubitemid 351793778)
22. Ha SK, Moon E and Kim SY: Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-kappaB and JNK activations in microglia cells. Neurosci Lett 485: 143-147, 2010.
23. Zhou X, Zhou YP, Huang GR, et al: Expression of the stem cell marker, Nanog, in human endometrial adenocarcinoma. Int J Gynecol Pathol 30: 262-270, 2011.
24. Jeter CR, Liu B, Liu X, et al: NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30: 3833-3845, 2011.
25. Noh EM, Lee YR, Hur H and Kim JS: Radix clematidis extract inhibits TPA-induced MMP-9 expression by suppressing NF-kappaB activation in MCF-7 human breast cancer cells. Mol Med Rep 4: 879-883, 2011.
26. Maeda S, Hikiba Y, Sakamoto K, et al: Colon cancer-derived factors activate NF-kappaB in myeloid cells via TLR2 to link inflammation and tumorigenesis. Mol Med Rep 4: 1083-1088, 2011.
27. Liu A, Chen H, Tong H, et al: Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-kappaB. Mol Med Rep 4: 221-227, 2011.
28. Franz S, Weidner N and Blesch A: Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury. Exp Neurol: Jan, 2011 (E-pub ahead of print).
29. Moore DL, Blackmore MG, Hu Y, et al: KLF family members regulate intrinsic axon regeneration ability. Science 326: 298-301, 2009.